Frontiers in glucagon-like peptide-2: Multiple actions, multiple mediators

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 2, 2007, Pages

  Dubé, Philip E ^a   Brubaker, Patricia L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

Growth; Intestine; Receptor; Signaling

Indexed keywords

BETA CATENIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; HORMONE ANALOG; KERATINOCYTE GROWTH FACTOR; SOMATOMEDIN C; TEDUGLUTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

APOPTOSIS; ATROPHY; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON MUCOSA; CRYPT CELL; ENDOCRINE CELL; ENTERITIS; ENTEROPATHY; HUMAN; INTESTINE BLOOD FLOW; INTESTINE CELL; INTESTINE INNERVATION; MYOFIBROBLAST; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SHORT BOWEL SYNDROME; SIGNAL TRANSDUCTION; TOTAL PARENTERAL NUTRITION;

ANIMALS; GLUCAGON-LIKE PEPTIDE 2; HUMANS; INTESTINAL MUCOSA; MODELS, BIOLOGICAL; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 34547618796     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00149.2007     Document Type: Review

References (46)

1. Bennett WR, Crew TE, Slack JM, Ward A. Structural-proliferative units and organ growth: Effects of insulin-like growth factor 2 on the growth of colon and skin. Development 130: 1079-1088, 2003.
2. Bjerknes M, Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98: 12497-12502, 2001.
3. Burrin DG, Stoll B, Guan X, Cui L, Chang X, Hadsell D. GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets. Am J Physiol Endocrinol Metab 292: E281-E291, 2007.
4. Burrin DG, Stoll B, Jiang R, Chang X, Hartmann B, Holst JJ, Greeley GH Jr, Reeds PJ. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: How much is enough? Am J Clin Nutr 71: 1603-1610, 2000.
5. Burrin DG, Stoll B, Jiang R, Petersen Y, Elnif J, Buddington RK, Schmidt M, Holst JJ, Hartmann B, Sangild PT. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am J Physiol Gastrointest Liver Physiol 279: G1249-G1256, 2000.
6. Cheeseman CI. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol Regul Integr Comp Physiol 273: R1965-R1971, 1997.
7. Davies M, Gupta S, Goldspink G, Winslet M. The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence. Int J Colorectal Dis 21: 201-208, 2006.
8. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20: 252-259, 2001.
9. Dubé PE, Brubaker PL. Glucagon-like peptide-2 acutely activates PKB/Akt and decreases apoptotic signaling in the mouse small intestinal epithelium. Gastroenterology 128: S1295, 2005.
10. Dubé PE, Forse CL, Bahrami J, Brubaker PL. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131: 589-605, 2006.
11. Dubé PE, Rowland KJ, Brubaker PL. Glucagon-like peptide-2 activates β-catenin signaling in mouse intestinal crypt through the insulin-like growth factor-1 pathway. Gastroenterology 132: S, 2007.
12. Ekelund M, Ekblad E. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide. Scand J Gastroenterol 36: 251-257, 2001.
13. Estall JL, Drucker DJ. Glucagon-like peptide-2. Annu Rev Nutr 26: 391-411, 2006.
14. Estall JL, Koehler JA, Yusta B, Drucker DJ. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation. J Biol Chem 280: 22124-22134, 2005.
15. Estall JL, Yusta B, Drucker DJ. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization. Mol Biol Cell 15: 3673-3687, 2004.
16. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: From endoderm to cancer. Genes Dev 19: 877-890, 2005.
17. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130: 150-164, 2006.
18. Guan X, Stoll B, Lu X, Tappenden KA, Holst JJ, Hartmann B, Burrin DG. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. Gastroenterology 125: 136-147, 2003.
19. He XC, Zhang J, Li L. Cellular and molecular regulation of hematopoietic and intestinal stem cell behavior. Ann NY Acad Sci 1049: 28-38, 2005.
20. Henriksen DB, Alexandersen P, Byrjalsen I, Hartmann B, Bone HG, Christiansen C, Holst JJ. Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. Bone 34: 140-147, 2004.
21. Hoosein NM, Gurd RS. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett 178: 83-86, 1984.
22. Iwakiri D, Podolsky DK. Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology 120: 1372-1380, 2001.
23. Kachra Z, Barash I, Yannopoulos C, Khan MN, Guyda HJ, Posner BI. The differential regulation by glucagon and growth hormone of insulin-like growth factor (IGF)-I and IGF binding proteins in cultured rat hepatocytes. Endocrinology 128: 1723-1730, 1991.
24. Koehler JA, Yusta B, Drucker DJ. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol Endocrinol 19: 459-473, 2005.
25. Lovshin J, Estall J, Yusta B, Brown TJ, Drucker DJ. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276: 21489-21499, 2001.
26. Lund PK. IGFs and the digestive tract. In: The IGF System: Molecular Biology, Physiology, and Clinical Applications, edited by Roberts CT and Rosenfeld RG. Totowa, NJ: Humana, 1999, p. 517-544.
27. MacDonald TT. Epithelial proliferation in response to gastrointestinal inflammation. Ann NY Acad Sci 664: 202-209, 1992.
28. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole AM, Gregorieff A, de Alboran IM, Clevers H, Clarke AR. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol Cell Biol 26: 8418-8426, 2006.
29. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96: 1569-1573, 1999.
30. Nelson DW, Sharp JW, Brownfield MS, Raybould HE, Ney DM. Localization and activation of GLP-2 receptors on vagal afferents in the rat. Endocrinology EPUB: 2007.
31. Niinikoski H, Stoll B, Guan X, Kansagra K, Lambert BD, Stephens J, Hartmann B, Holst JJ, Burrin DG. Onset of small intestinal atrophy is associated with reduced intestinal blood flow in TPN-fed neonatal piglets. J Nutr 134: 1467-1474, 2004.
32. Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124: 105-112, 2005.
33. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 17: 1709-1713, 2003.
34. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West Myofibroblasts AB II. Intestinal subepithelial myofibroblasts. Am J Physiol Cell Physiol 277: C183-C201, 1999.
35. Ramsanahie A, Duxbury MS, Grikscheit TC, Perez A, Rhoads DB, Gardner-Thorpe J, Ogilvie J, Ashley SW, Vacanti JP, Whang EE. Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol 285: G1345-G1352, 2003.
36. Sams A, Hastrup S, Andersen M, Thim L. Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines. Eur J Pharmacol 532: 18-23, 2006.
37. Sandgren K, Lin Z, Svenningsen AF, Ekblad E. Vasoactive intestinal peptide and nitric oxide promote survival of adult rat myenteric neurons in culture. J Neurosci Res 72: 595-602, 2003.
38. Shin ED, Estall JL, Izzo A, Drucker DJ, Brubaker PL. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128: 1340-1353, 2005.
39. Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, Tanaka H, Sharkey KA. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol [EPUB ahead of print: doi:0.1152/ajpgi.00530.2006].
40. Thulesen J, Hartmann B, Hare KJ, Kissow H, Orskov C, Holst JJ, Poulsen SS. Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut 53: 1145-1150, 2004.
41. Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, Brubaker PL. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144: 4385-4392, 2003.
42. Washizawa N, Gu LH, Gu L, Openo KP, Jones DP, Ziegler TR. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats. J Parenter Enteral Nutr 28: 399-409, 2004.
43. Wu KK. Regulation of endothelial nitric oxide synthase activity and gene expression. Ann NY Acad Sci 962: 122-130, 2002.
44. Yusta B, Estall J, Drucker DJ. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J Biol Chem 277: 24896-24906, 2002.
45. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119: 744-755, 2000.
46. Yusta B, Somwar R, Wang F, Munroe D, Grinstein S, Klip A, Drucker DJ. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor. J Biol Chem 274: 30459-30467, 1999.